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SAMPLE SIZE DETERMINATION IN ANIMAL HEALTH STUDIES 
 
Zhanglin Cui, Alan G. Zimmermann and Daniel H. Mowrey 
Statistics and Information Sciences 
Eli Lilly and Company 




Oftentimes in animal health studies, a treatment group is randomly assigned to a pen of animals, 
and the pen of animals as a whole is treated (fed the same medicated feed or water) together.  In 
this scenario, the pen of animals is the experimental unit and the individual animal may be an 
observational unit.  In addition to having the pen as the experimental unit, if multiple sites are 
used and site is treated as a random factor, this adds complexity to the study.  To properly design 
the study, it is necessary to determine the number of animals in a pen, the number of pens per 
treatment group, and the number of sites in order to detect treatment differences with desired 
power.  The method for sample size determination depends on the statistical distribution of the 
primary endpoint in the study, the design of the study, and the proposed statistical analysis 
method.  Focusing on the case where individual animal is not the experimental unit, this paper 
demonstrates methods and discusses issues for sample size determination in animal health 
studies with continuous or binary primary endpoints, and gives a simple approach for 
determining an appropriate number of sites in a multi-site model analyzed with a linear mixed 
model.  
 
Key words  sample size, power, experimental unit, experimental design, randomized complete 
block design, binomial distribution, normal distribution 
 
 
1.  INTRODUCTION 
 
Sample size is important in making statistical inferences. A researcher should use an adequate 
sample size to effectively address research questions. Sample size usually refers to the number of 
experimental units in a treatment group. The experimental unit is defined as the smallest unit to 
which a treatment is randomly assigned and applied. 
 
This paper demonstrates methods and discusses issues for sample size determination in animal 
health studies with continuous or binary primary end points. 
 
 
2. EXPERIMENTAL UNIT IN ANIMAL HEALTH STUDIES 
 
In animal health studies, the experimental unit could be an individual animal, a pen, a tank, a 
raceway, or a herd. A treatment group is randomly assigned to a pen of animals, and the pen of 
animals as a whole is treated (given the same medicated feed or water) together.  In this scenario, 





the pen of animals is the experimental unit and the individual animal may be an observational 
unit.  In addition to having the pen as the experimental unit, multiple trial sites treated as a 
random factor create additional complexity for the study design.   
 
To properly design the study, it is first necessary to estimate the pen-to-pen variability and 
determine the number of animals in a pen (i.e. pen size), then the number of pens per treatment 
group (i.e. sample size), and finally, for multi-site studies, the number of sites necessary to detect 
treatment differences at a predetermined power.  For multi-site studies with a randomized 
complete block design (RCBD) within each site, the sample size is the product of the number of 
blocks per site and the number of sites.  
 
 
3. ESTIMATION OF PEN-TO-PEN VARIABILITY  
 
When pen is the experimental unit and also the observational unit in a completely randomized 
design, the observation yij on ith treatment and jth pen can be fitted in a linear model, 
 
yij = µ + τi + eij     (1) 
 
where µ is the overall mean, τi the fixed treatment effect, and eij the random pen effect with eij ~ 
N (0, σ2pen) where σ2pen is the pen-to-pen variability. Often, the pen-to-pen variability can be 
estimated from a set of historical data or pilot studies.  
 
When pen is the experimental unit and individual animal is the observational unit in a completely 
randomized design, the above model is still the most appropriate model. To apply the model, the 
means for a continuous endpoint, the means for a count endpoint, or the proportions for a binary 
endpoint should be calculated for each pen. Appropriate data transformations may be needed 
prior to model estimation to meet the normal distribution assumption. The variance components 
for residual, eij, can be then calculated from the pen-based mean model and used in sample size 
determinations for future studies.  
 
To further examine the variance components for the pen-to-pen variability when pen is the 
experimental unit and individual animal is the observational unit, the observation yijk on ith 
treatment, jth pen, and kth animal can be modeled as, 
 
yijk = µ + τi + pij + e*ijk     (2) 
 
where µ is the overall mean and τi is the fixed treatment effect. The random pen effect pij ~ N (0, 
σ2p), σ2p is the variance component due to pen while e*ijk ~ N (0, σ2e), σ2e is the variance 
component due to animal. 
 
Averaging equation (2) over animals within pens yields: 
 






••  +  +  + = ijijiij epτµ  y      (3) 
 
The sum of pij and 
∗
•ije  is equivalent to eij of pen as observational unit. The pen-to-pen variability, 
σ2pen = Var(pij + 
∗
•ije ) = σ2p + σ2e/m, which includes variability due to m animals (σ2e/m) and 
variability due to pen (σ2p). Increasing the number of animals per pen will reduce part of the pen-
to-pen variability. However, it is not possible to separate these two components from the model 
yij = µ + τi + eij which is more appropriate when pen is the experimental unit and individual 
animal is the observational unit in a completely randomized design.  In addition, the typical 
assumption of independence among the ∗ijke  (i.e. independence among animals in a pen) is not 
true in practice and the variability due to animal may not be exactly σ2e/m.  
 
In multi-site studies, the variance components for both the residual and the site*treatment 
interaction terms must be calculated in order to determine the number of sites and number of 
replications. For binary variables, pen-to-pen variability can be calculated based on the binomial 
distribution if there is no extra-binomial variation. More details on the pen-to-pen variability for 
the binary variables will be presented in later sections. 
 
 
4. PEN SIZE DETERMINATION 
 
Ideally, the most appropriate way to determine the pen size is to conduct a study with a varying 
number of animals per pen. The variability among pens could then be calculated for each of the 
different pen sizes with the general expectation that the variability decreases when the pen size 
increases. Studies such as this are useful to determine pen size; however they do not determine 
sample sizes with regard to number of experimental units (pens). If pen size cannot be 
determined by experimentation, then a subjective method is required. 
 
To determine the pen size subjectively, many different practical factors may need to be 
considered, such as commercial feedlot practice, regional differences, animal management 
standards, and budget. Sometimes, animal biological characteristics and limitations also play 
important roles in pen size determination. For example, in pig studies, pen size should be less 
than 20 head per pen. This is because pigs can only recognize and live harmoniously with a 
limited number of pen mates. Pens with more than 20 animals usually result in fighting among 
the pigs before the establishment of a harmonious social order and a study with many injured and 
early removed pigs. In other cases with mixed genders, intact males and non-pregnant females 
are required and pen size can be as small as one animal per pen, or more than one animal per pen 
if genders are separated in different pens or if castrated males and/or spayed females are used,.  
 
As shown earlier, pen size determines part of the pen-to-pen variability and, in turn, sample size. 
If m is the pen size, i.e. the number of animals per pen, the pen-to-pen variability decreases as m 
increases. Assuming there is no physical pen effect and responses of animals within a pen are 





independent, the observed pen-to-pen variability s2pen has an expected value σ2animal/m. In fact, the 
above assumption is not true in animal health studies. Animals within a pen interact with each 
other, creating additional covariances. There may be other differences between pens that are not 
directly related to how many animals are in the pen as well. The animals are of course different 
in each pen, creating a unique pen effect.  In brief, there is pen-to-pen variability apart from what 
the animal variability with variance that changes proportionally with 1/m.   
 
If the endpoint is binary in nature, e.g. success versus failure, then Figure 1 gives some guidance 
on the number of animals per pen.  It can be seen that, as number of animals per pen increases, 
the pen-to-pen standard deviation (SD) decreases, resulting in a decrease in sample size (number 
of pens) and increase in total number of animals. The total number of animals per treatment 
group is the product of number of animals per pen and the sample size. More details about Figure 
1 will be given in Section 5.2. 
 
 
5. SAMPLE SIZE DETERMINATION 
 
5.1. Continuous Endpoint 
 
Continuous endpoints in animal health studies, such as body weight, milk yield, lean meat yield, 
and protein content, measure quantitative responses of animals to a treatment. Assume a 
comparative study with two treatment groups, n experimental units per treatment group, and m 
animals per pen. Here, the pen is the experimental unit while individual animals are the 
observational units.  Assume that a completely randomized design is used to assign treatments to 
pens.   
 
Let AY  and BY  be the pen means of a continuous normally-distributed variable for treatment 
groups A and B, respectively. Assume that both groups have a common variance σ2 with 
estimate s2 from a linear mixed model or ANOVA based on 2n-2 degrees of freedom. The mean 
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If the test size is α, the one-sided critical value will be 
n
2σZα . Denote the power to be 1-β, thus 
the probability to have the observed treatment difference exceed the critical value is given by:  
β1)
n
2σZP(D α −=>  
 
Now setting the quantity 
n
2σ








To ensure the power, the observed treatment difference D must exceed the critical value 
n
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≥  for two-sided test,  
 
where σ2 is the pen-to-pen variability estimated by the observed s2; δ is the expected mean 
treatment difference estimated by the observed treatment difference based on the pen means. 
 
In general, the student t-distribution is often used instead of normal distribution to calculate the 
sample size leading to larger estimates.  
 
Example I. Compound R in feed for growth performance in turkeys. In this study, the 
primary efficacy variable was average daily gain (ADG, kg/day/head). A pen size of m = 10 
turkeys per pen was determined by the investigator. Based on a previous pilot study, the pen-
based ADG for the control group was 0.321 kg/day/head which was assigned to be the 
population mean µB. A 7% increase in ADG is expected for the group treated with compound R 
in a new study. Thus the expected ADG for the treatment R group is assumed to be µA = 
0.312+0.312*0.07=0.34347 kg/day/head. The treatment difference is δ = 0.34347- 0.321 





=0.02247. The common standard deviation derived from the residual error term of a linear mixed 
model analysis of the pilot study was s = 0.0214. Given the test size α = 0.05, power (1-β) = 












5.2. Binary Endpoint 
 
Binary endpoints in animal health studies, such as success versus failure, positive versus 
negative, present versus absent, measure qualitative responses of animals to a treatment. Assume 
a comparative study with 2 treatment groups, n experimental units per treatment group, and m 
animals per pen. Here, the pen is the experimental unit while individual animals are the 
observational units. Further assume that a completely randomized design is used to assign 
treatments to pens.  The endpoint variable is treatment success or failure in a therapeutic study. 
The proportion of success is calculated on each pen. The drug treated group (A) has a mean 
success rate µA = pA and variance σ2A = pA(1-pA)/mA; while the control group (B) has a mean 
success rate µB = pB and variance σ2B = pB(1-pB)/mB. The common pen-to-pen variability can be 
estimated as follows.  
 
                          2s  ≈ (σ2A + σ2B)/2 = (pA(1-pA)/mA + pB(1-pB)/mB)/2 
 
                          )/2)/mp(1p)/mp(1(ps BBBAAA −+−≈  
 
Note that this estimate assumes that the pen-to-pen variability is due only to the number of 
animals per pen, and not due to any other differences between pens (such as physical location of 
pens) that may lead to extra-binomial variation.  In situations where extra-binomial variation is 
anticipated, it is advisable to obtain pilot data or use data from past similar studies and estimate 
the common pen-to-pen variability from a linear mixed model analysis or ANOVA. 
 
Example II. Compound T in feed for the control of disease B in cattle. The primary efficacy 
variable was the binary treatment outcome, success versus failure, for each individual animal at 
the end of the treatment phase (Study Day 28). The success rate was calculated as the ratio of the 
number of success animals to the total number of animals evaluated in a pen. In a previous study, 
the success rate for the compound T treated group was pA = 0.554 while the success rate for the 
control group was pB = 0.314. The treatment difference in success rates was therefore δ = 0.554 - 
0.314 = 0.24. To aid the design of the study, pen sizes between 1 and 30 animals per pen were 
considered in the sample size determination process (Figure 1). At each pen size the 
corresponding pen-to-pen standard deviation (SD), the sample sizes, and total number of animals 
were calculated based on the 80% power and a one-sided t-test at the 5% significance level. It 
can be seen that, as the pen size increases from 1 to 10 animals per pen, the sample size 
decreases dramatically; whereas, when the pen size is over 10, the sample size does not change 





much. Adding additional animals beyond 10 to the pen will increase the total number of animals 
in the study and, in turn, increase the cost of the study without a corresponding gain in the study 
power.  A pen size of m = 12 calves per pen was determined by the investigator. The estimated 
common standard deviation in terms of rate of success animals was calculated: 
 
                      s =  )/2)/mp(1p)/mp(1(p BBBAAA −+−  
                         = 20314)/12)/(1*0.3140.554)/12(1*(0.554 −+−  
                         =  0.13882 
 
Given the test size α = 0.05, power (1-β) = 90%, and a one-sided t-test, the sample size of 7 pens 
per treatment group was calculated:   
 









Alternatively, the common standard deviation in terms of the number of success animals could 
have been calculated: 
 
                   s = ))/2p(1pm)p(1p(m BBBAAA −+−  
                      = 0314))/2(1*0.314*120.554)(1*0.554*(12 −+−  
                      =  1.6658 
 
The estimation of expected average number of success animals in T treated group would have 
been µA = 12*55.4% = 6.648 animals/pen and in the control groups µB = 12*31.4% = 3.768 
animals/pen. The treatment difference in success rates would be δ = 6.648 – 3.768 = 2.88. Given 
the test size α = 0.05, power (1-β) = 90%, and a one-sided t-test, the sample size of 7 pens per 
treatment group was again calculated: 










5.3. Continuous Endpoint with Multiple Sites 
 
Typically, animal health phase III clinical studies are conducted at multiple sites with a 
randomized complete block design at each site. Common blocking factors are pen location 
within a facility, gender, parity, initial body weight, or initial flea count. The sample size per 
treatment is the product of number of blocks per site and the number of sites. Appropriate 
combinations of number of blocks per site and the number of sites could significantly reduce the 
study cost.  
   





The study data are usually analyzed using a linear mixed model with treatment as fixed effect 
and site, site*treatment, and block(site) as random effects. A covariate such as initial body 
weight, initial flea count, or initial milk yield is often included in the model, but this is not 
discussed here. Site heterogeneity may be tested using Levene’s test. 
 
Briefly, sample size determination for multiple site trials include the following three steps: (1) 
Estimate variance components for residual ( 2eσ ) and site*treatment (
2
tτσ ), (2) Compute the 
variance of differences between treatment means ( ( )2i1i yyVar •• − ), and (3) Calculate sample size 
as the number of sites for a specified number of blocks per site. Details of the sample size 
determination follow. 
 
The model can be expressed as 
( ) ijkeiktτkτijbitµyijk +++++=  
where  
µ = overall mean; 
ti = random effect of ith site, i = 1, 2, …, I ; 
bij = random effect of jth block at ith site, j= 1,…, J; 
τk = fixed effect of kth treatment, k = 1, …, K (often, K=2); 
(tτ)ik = random effect of site*treatment interaction; 
eijk = residual. 
 
All the random effects are treated as being independent. The variance components in the model 
are  
                                      ( ) 2ti σtVar =                   ( ) 2bij σbVar =  
                                     ( )[ ] 2tτik σtτVar =               ( ) 2eijk σeVar =  
 
The important variance components will be those for residual ( 2eσ ) and site*treatment (
2
tτσ ).  
These are the only two estimates which we will need for the sample size determination. 
 
Using a “dot” and bar to represent averaging for site*treatment means, we have  
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The model for difference between site*treatment means becomes a very simple one-sample 
model 





( ) ( ) I1,...,ifor   ,eeττyy 2i1i212i1i =−+−=− ∗•∗•••  














With estimates for residual ( 2eσ ) and site*treatment (
2
tτσ ), for several different values of J we 
calculate the necessary sample size in terms of the number of sites I. Given these variances, the 
sample size can be calculated using software or formulas for one-sample model or a paired t-test. 
 
Example III. Sample Size Determination for Multi-Site Studies. Example values of variance 
components and resulting sample sizes are given in Table 1.  Note that for larger number of 
blocks per site, the number of sites required is reduced.  The amount of change in required 
number of sites will depend on the relative size of the variance components.  The sample size is 
calculated with 2-sided test at 0.05 significance level and 80% power.  
 
 
6.  SUMMARY 
 
Sample size determination includes the number of animals per pen, the number of pens per 
treatment group, and the number of trial sites, when designing an animal health study with the 
pen of animals as the experimental unit. There are processes to determine an appropriate pen 
size, however pen size determination is often subjective depending on multiple practical and 
biological factors. Pen size can affect the pen-to-pen variability and hence the number of pens, 
and thus the number of animals in a study. For continuous endpoints or binary endpoints, the 
pen-to-pen variability can be estimated from a linear mixed model analysis of pen-based means. 
For multiple sites studies, sample size can be calculated based on the variance components for 
site*treatment and residual. 
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12 10 2 2*17 20 23 
12 10 3 2*15.3 20 19 
12 10 4 2*14.5 20 17 
12 10 5 2*14 20 16 
5 10 2 2*10 20 8 
5 10 3 2*8.3 20 6 
5 10 4 2*7.5 20 5 
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Note: The X-axis is the pen size (i.e. the number of animals per 
pen). The Y-axis is simply the magnitude of the pen-to-pen 
variability (i.e. standard deviation, SD), the sample size (i.e. 
number of pens, Pens), and the number of animals per treatment 
group (Animals).    
 
Pen Size=12 
SD = 0.139 
Pens = 7 
Animals = 84 
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